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INTRODUCTION
Antibiotic tolerance is one of the main features that is making Mycobacterium abscessus a global health problem. Mycobacterium abscessus is an environmental microorganism, often found in soil and water (Halstrom, Price and Thomson 2015) , that can cause lung infection in vulnerable hosts with underlying structural lung disease (Lee et al. 2015) , and is increasingly being isolated from respiratory samples of cystic fibrosis (CF) patients. The reported transmissibility of M. abscessus between individuals (Bryant et al. 2013 (Bryant et al. , 2016 , acquisition of the infection at a young age (Qvist et al. 2014; Park and Olivier 2015; CamposHerrero et al. 2016) and its impact on lung function decline (Qvist et al. 2016) highlight the importance of studying this microorganism in the CF patient population.
Mycobacterium abscessus lung infection treatment lasts 12 months and includes the use of antibiotics that are selected based on results of in vitro susceptibility testing and the toxicity profile of the drug (Flume 2016) . A typical regimen against M. abscessus includes clarithromycin in combination with amikacin and imipenem, cefoxitin or tigecycline. However, the therapeutic failure and recurrence is high, and drug-related toxicity appears frequently (Martiniano, Nick and Daley 2016; Pasipanodya et al. 2017) .
Recently, biofilm formation of M. abscessus in the respiratory zone of the lungs of CF patients has been demonstrated (Qvist et al. 2015) . Although this biofilm growth mode might be contributing to therapeutic failure, it is well known that in vivo biofilms are mostly polymicrobial (Burmolle et al. 2010; Sibley and Surette 2011; Peters et al. 2012; Tay, Chong and Kline 2016) and potential interactions between species sharing the same niche should be considered when evaluating antibiotic therapy (Roder, Sorensen and Burmolle 2016; Tavernier et al. 2017; Vandeplassche, Coenye and Crabbé 2017) . Nevertheless, there are few studies focusing on M. abscessus interspecies interactions.
One of the pathogens often co-isolated with M. abscessus in CF patients is Pseudomonas aeruginosa (Levy et al. 2008; Binder et al. 2013; Viviani et al. 2016) . A recent study by Birmes et al. (2017) showed that, when co-cultured, some strains of M. abscessus are able to degrade P. aeruginosa quorumsensing molecules HHQ (2-heptyl-4(1H)-quinolone) and PQS (Pseudomonas quinolone signal), suggesting a competitive advantage of M. abscessus against P. aeruginosa. Indeed, antimicrobial therapy in CF seems to be a risk factor for pulmonary infection by M. abscessus (Catherinot et al. 2013) , given its intrinsic resistance to conventional antimicrobials.
In order to take into account host-pathogen interactions and to provide more reliable and predictive information about the infection process, in vitro three-dimensional (3-D) cell culture models have been developed. Three-dimensional cell culture models of lung tissue, derived from alveolar epithelial cells (A549 cell line), show expression of specific epithelial cell markers indicative of barrier function, polarity and multicellular complexity, thus reflecting key aspects of the in vivo parental tissue (Carterson et al. 2005; Barrila et al. 2010; Crabbé, Ledesma and Nickerson 2014; Crabbé et al. 2017) . Recently, P. aeruginosa was demonstrated to form antibiotic-resistant biofilms on 3-D lung epithelial cells without affecting host cell viability and differentiation .
The poor correlation between in vitro and in vivo makes it important to understand the in vivo factors that may influence the outcome of the therapy. For that purpose, mimicking both the in vivo bacterial phenotype and the host microenvironment can improve the correlation between in vitro and in vivo antibiotic efficacy. Our objective is to evaluate the effect of antibiotics commonly used to treat respiratory infection in CF in M. abscessus biofilm formation in the presence of (i) another major CF pathogen frequently co-isolated with M. abscessus (i.e. P. aeruginosa) and (ii) in vivo-like 3-D lung epithelial cells.
MATERIALS AND METHODS

Bacterial strains and culture conditions
Clinical strains isolated from sputum samples of different patients with chronic pulmonary disease were used: P. aeruginosa strain was isolated from a CF patient and presented a mucoid phenotype, while M. abscessus subsp. massiliense was isolated from a patient with bronchiectasis and showed a smooth colony phenotype. According to ATS/IDSA criteria (Griffith et al. 2007 For the inhibition studies, the cultures were centrifuged (5 min, 4500 × g), resuspended in host cell culture media (GTSF-2) and then diluted to an optical density (λ = 595 nm) of 0.05 in the case of P. aeruginosa, and 0.2 in the case of M. abscessus, both corresponding to ∼5 × 10 7 CFU/mL.
Antimicrobial agents
For the inhibition studies, four antibiotics were chosen based on their use to treat pulmonary infections in CF patients by (i) P. aeruginosa (colistin and ceftazidime), (ii) both P. aeruginosa and M. abscessus (amikacin), or (iii) M. abscessus (clarithromycin). All antibiotics were purchased from Sigma-Aldrich or TCI. Antibiotic stocks were made, according to the solubility of each antibiotic, in MQ water for amikacin (50 mg/mL) and colistin (50 mg/mL), in MQ water supplemented with anhydrous sodium carbonate for ceftazidime (11 mg/mL) and in DMSO for clarithromycin (1.1 mg/mL).
Inhibition of bacterial association with an abiotic surface
The inhibition of biofilm formation on a plastic surface was carried out as published previously ) with minor modifications. The antibiotics used were amikacin (17 μg/mL), clarithromycin (1.1 μg/mL), colistin (2 μg/mL) and ceftazidime (256 μg/mL) diluted in the host cell culture medium, i.e. GTSF-2 medium supplemented with 2.5 mg/L ITS, 1.5 g/L sodium bicarbonate, and 10% FBS (Invitrogen). Following addition of the antibiotics, P. aeruginosa and M. abscessus were added to the solutions at a final concentration of 2.5 × 10 7 CFU/mL each (proportion 1:1). Single-species biofilm controls of P. aeruginosa and M. abscessus were included for each condition. Biofilms were formed on the surface of flat-bottomed 96-well microtiter plates (MTP) by adding 100 μL/well of the bacterial suspension, supplemented or not with antibiotics. MTPs were incubated statically for 6 h at 37
• C. Antibiotic concentrations were determined empirically to obtain inhibition of 1 to 2 log units of at least one species, while maintaining dual-species biofilms post-treatment on a plastic surface. This allowed us to observe differences in antibiotic efficacy against single-versus dualspecies biofilm formation and to compare association with plastic or with the 3-D lung epithelial cell model. After 6 h, the culture media was removed and biofilms were rinsed twice with sterile saline solution (SS) to remove non-adherent cells, filled again with SS, vortexed, sonicated and serially diluted. Viable counts of each bacteria were determined by drop plating serially diluted samples onto two selective media (MacConkey Agar and Columbia Colistin Nalidixic Acid Agar with 5% Sheep Blood). Pseudomonas aeruginosa colonies on MacConkey agar were counted after 24 h of incubation, whereas M. abscessus colonies on CNA agar were counted after 72 h.
Inhibition of bacterial association with 3-D human lung epithelial cells
Three-dimensional lung models were derived from the human epithelial cell line A549 and cultured in GTSF-2 supplemented with 2.5 mg/L ITS, 1.5 g/L sodium bicarbonate and 10% heatinactivated fetal bovine serum (Invitrogen) as described previously (Carterson et al. 2005; Crabbé et al. 2011) . On the day of infection, the 3-D aggregates were removed from the RWV bioreactor and placed into 48-well plates (2.5 × 10 5 cells/well). In each well, antibiotics and bacteria were added to reach the same concentration as in the inhibition study on a plastic surface (final volume of 250 μL/well), being the multiplicity of infection in the multispecies cultures 50:1, and in the monospecies cultures 25:1. The plate was incubated statically for 6 h in a 5% CO 2 atmosphere at 37
After the incubation, the number of bacteria infecting the cells was quantified as published previously (Anderson et al. 2008; Tran et al. 2014; Crabbé et al. 2017) . Briefly, the 3-D aggregates were transferred in a new 48-well plate and washed two times with Hank's Balanced Salt Solution to remove nonadherent bacteria. The adhered and intracellular bacteria were quantified after lysing the cells with 1% Triton-X and plating serial dilutions of the lysates on selective media (MacConkey Agar and Columbia CNA Agar with 5% Sheep Blood).
Evaluation of 3-D aggregate morphology and cell viability
To assess overall morphology and integrity of the 3-D cell aggregates, light microscopic imaging was performed at a magnification of ×300 with an EVOS FL Auto Imaging System (Life Technologies). Thereafter, epithelial cells were detached from the microcarrier bead scaffolds using 0.25% Trypsin-EDTA and stained with fluorochrome-labeled Annexin V and propidium iodide (Thermo Fisher Scientific R ) for quantification of apoptotic and necrotic cells using an Attune flow cytometer (Life Technologies) according to the manufacturer's instructions.
Statistical analysis
All the experiments were performed at least in biological triplicate, except for cell viability that was performed in biological duplicate. The technical and the biological variability between replicates were below 25% in all the experiments. The normal distribution of the data was assessed using the Shapiro-Wilk test. The means of the log CFU/mL for each experiment were compared with an ANOVA test when the number of conditions was more than two. If the comparison was made between two conditions, then an independent-sample t-test was performed. Statistical significance was considered when P-value was less than or equal to 0.05.
RESULTS
Mycobacterium abscessus and P. aeruginosa develop dual-species communities on plastic and 3-D lung epithelial cells
After 6 h of infection, M. abscessus and P. aeruginosa were recovered in similar absolute abundances in the dual-species biofilm both on a plastic surface (Fig. 1A) and on 3-D lung epithelial cells (Fig. 1B) . The bacterial density of each species in the dual-species biofilm on plastic was not different from the density in singlespecies biofilms. However, in the presence of 3-D lung epithelial cells, a decrease in M. abscessus biofilm formation was observed in dual-compared to single-species biofilms (P < 0.05).
The integrity of the 3-D cell aggregates and epithelial cell viability was not affected by the presence of single-or dualspecies biofilms, with epithelial cell viability in all conditions being higher than 85% (Fig. S1 , Supporting Information).
Antibiotic efficacy against M. abscessus and P. aeruginosa single-and dual-species biofilms
During this study, antibiotic efficacy was evaluated in four model systems with increasing complexity: (i) single-species biofilms of P. aeruginosa or M. abscessus on a plastic surface, (ii) dualspecies biofilms of P. aeruginosa and M. abscessus on a plastic surface, (iii) single-species biofilms of P. aeruginosa or M. abscessus on 3-D lung epithelial cells, (iv) dual-species biofilms of P. aeruginosa and M. abscessus on 3-D lung epithelial cells.
Antibiotic efficacy in preventing biofilm formation on plastic was tested on single-and dual-species cultures of P. aeruginosa and M. abscessus, and the results are shown in Fig. 1A . Pseudomonas aeruginosa grown as single-and dualspecies biofilms was inhibited by all tested antibiotics (P ≤ 0.01). For M. abscessus, a significant increase in the biofilm formation was observed when the single-species biofilms were treated either with clarithromycin (36.67 × MIC, 0.37 ± 0.12 log, P = 0.025), colistin (0.43 ± 0.12 log, P = 0.008) or amikacin (8.5 × MIC, 0.58 ± 0.13 log, P = 0.001). In the dual-species biofilm on a plastic surface, there was an increase in the bacterial density of M. abscessus when the biofilm was treated with amikacin (0.47 ± 0.12 log, P = 0.004) or clarithromycin (0.37 ± 0.11 log, P = 0.013).
The results of the antibiotic efficacy in preventing association with 3-D lung epithelial cells are shown in Fig. 1B . All antibiotics resulted in a statistically significant decrease in association with the 3-D cells for P. aeruginosa single-and dual-species cultures (P < 0.01), except for clarithromycin which was ineffective (P > 0.05). For M. abscessus, association with the 3-D lung epithelial cells in single-and dual-species cultures was not inhibited by antibiotic treatment. As opposed to the results on plastic, no biofilm induction of M. abscessus was observed in the presence of antibiotics.
Influence of interspecies interactions on antibiotic efficacy
The results of the comparison of single versus dual biofilm inhibition with antibiotics are shown in Fig. 2 . When M. abscessus was grown in a dual-species biofilm with P. aeruginosa on a plastic surface, ceftazidime inhibited biofilm formation more effectively (P < 0.01) as compared to the single-species biofilms of M. abscessus, whose formation was induced when treated with this antibiotic.
On the 3-D epithelial cell model, our data showed an overall trend of decreased efficacy of antibiotics against M. abscessus when grown together with P. aeruginosa, with colistin reaching statistical significance (P < 0.01).
For P. aeruginosa, no significant differences were observed in antibiotic efficacy with or without M. abscessus for any of the tested antibiotics, both on abiotic and biotic surfaces.
Influence of 3-D lung epithelial cells on antibiotic efficacy
The biofilm inhibition on plastic or 3-D lung epithelial cells was compared (Fig. 3) .
For P. aeruginosa, an overall trend was observed for a more effective biofilm inhibition both for single-and dual-species biofilms in the 3-D lung epithelial model. Statistical significant differences between models were found when the single-species biofilm of P. aeruginosa was treated with ceftazidime (P < 0.05) and the dual-species biofilm with colistin (P < 0.01). With clarithromycin, the opposite effect was found: clarithromycin inhibited more effectively the development of single (P < 0.01) and dual (P < 0.05) biofilms of P. aeruginosa on a plastic surface as compared to 3-D lung epithelial cells.
Regarding M. abscessus single-species biofilms, a more effective biofilm inhibition was observed in the 3-D lung epithelial model compared to plastic with all of the antibiotics (P < 0.01) since induction of biofilm formation by antibiotics was not observed in the presence of 3-D cells. M. abscessus biofilm induction in dual-species biofilms was, in general, less pronounced in the 3-D lung epithelial model as compared to a plastic surface, with amikacin reaching statistical significance (P < 0.05). In contrast, ceftazidime treatment of dual-species biofilms inhibited M. abscessus biofilm formation in the plastic model, compared to the 3-D lung epithelial cells (P < 0.05).
DISCUSSION
The poor correlation between in vitro susceptibility testing results and in vivo outcomes makes it necessary to develop models that are able to predict the success or failure of a treatment. For that purpose, mimicking the in vivo phenotype of the bacteria, the host and its microenvironment may help us understand the underlying causes for the discrepancies between in vitro and in vivo antibiotic efficacy. Indeed, it is well known that bacteria grow as biofilms in CF and are polymicrobial in nature (Quinn et al. 2016; Roder, Sorensen and Burmolle 2016; Vandeplassche, Coenye and Crabbé 2017) . Interactions between species sharing the same niche can have synergistic or antagonistic effects in the response to antibiotics; thus, the community has to be considered when evaluating antibiotic treatment (Beaudoin et al. 2017; Lopes, Azevedo and Pereira 2017; Tavernier et al. 2017) . Furthermore, host epithelial cells have been shown to influence the antibiotic efficacy of several microorganisms, including P. aeruginosa (Anderson et al. 2008; Crabbé et al. 2017) In order to mimic aspects of the in vivo situation, we incorporated interactions of M. abscessus with the commonly co-isolated bacteria P. aeruginosa and physiologically relevant 3-D lung epithelial cells when evaluating the efficacy of antibiotics commonly employed in the treatment of CF.
It was observed that M. abscessus was capable of developing dual-species communities with P. aeruginosa on different surfaces (plastic and 3-D lung epithelial cells) and that both species were present in similar absolute abundances, although P. aeruginosa is a fast-growing bacteria (LaBauve and Wargo 2012) and M. abscessus rate of growth is lower (Brown-Elliott and Wallace 2015) .
Our results showed that M. abscessus response to antibiotics was influenced by the presence of P. aeruginosa, but not vice versa. In particular, P. aeruginosa prevented induction of M. abscessus biofilm formation following treatment with ceftazidime on plastic. Meanwhile, in the 3-D lung epithelial model P. aeruginosa improved M. abscessus association with the 3-D cells after treatment with colistin. We also observed that 3-D lung epithelial cells influence the antibiotic efficacy against both P. aeruginosa and M. abscessus. Notably, the efficacy of clarithromycin against P. aeruginosa was strongly inhibited by 3-D lung cells. A possible explanation is that macrolides such as clarithromycin accumulate intracellularly, as opposed to most other antibiotic classes (Carryn et al. 2003) . This could result in a lower bioavailability of clarithromycin in the presence of 3-D lung epithelial cells. Our results also indicated that the antibiotics commonly employed to treat chronic infection (colistin) or exacerbations (ceftazidime) caused by P. aeruginosa were more effective in inhibiting dual-and single-species biofilm formation in the 3-D cell model compared to on plastic. Differences in antibiotic efficacy against single-species P. aeruginosa biofilm formation were observed when grown on plastic versus 3-D lung epithelial cells, depending on the antibiotic being used . However, ceftazidime efficacy against P. aeruginosa biofilm formation was previously described not to be influenced by 3-D lung epithelial cells ); yet this was tested on the laboratory strain PAO1 indicating presumable strain-dependent effects. Enhanced antibiotic efficacy in the presence of epithelial cells can be due to synergistic effects between antibiotics and epithelial endogenously produced antimicrobial peptides, such as β-defensins (Bals 2000; Schutte and McCray 2002; Sim et al. 2009 ). Another main difference between both model systems is that we observed M. abscessus biofilm induction by antibiotics on a plastic surface but not on the 3-D lung epithelial cells. Biofilm formation can be induced by sub-MIC concentrations of antibiotics (Kaplan 2011) and, although expected from antibiotics with no effect against M. abscessus, such as colistin and ceftazidime, it was surprising to obtain this result with amikacin and clarithromycin, both active in vitro against M. abscessus, and added to the inhibition assay at 8.5 and 36.67 times the MIC, respectively.
When focusing on our most physiologically relevant model (i.e. dual-species biofilms on 3-D lung cells), it was observed that treatment with antibiotics in the early stages of biofilm formation could inhibit P. aeruginosa biofilm growth mode, with the exception of clarithromycin, while no effective inhibition was seen in the case of M. abscessus. This resulted in a competitive advantage for M. abscessus in dual-species biofilms for all tested antibiotics, except again for clarithromycin. Thus, antibiotic therapy in CF typically targeting P. aeruginosa in the initial stages of biofilm formation could lead to a competitive advantage in lung epithelial colonization to M. abscessus over P. aeruginosa.
In conclusion, our study demonstrated that inhibition of M. abscessus and P. aeruginosa biofilm formation is influenced by host epithelial cells and interspecies interactions. Our results highlight the importance of understanding the role that in vivo host and bacterial factors play in the efficacy of antibiotics. Hence, this knowledge could lead to the development of models that enable stronger correlation between in vitro studies and in vivo outcomes. We also found a competitive advantage for M. abscessus in dual-species biofilms for several tested antibiotics suggesting that therapy targeting P. aeruginosa in the early stages of biofilm formation may favor M. abscessus epithelial lung colonization.
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